ALEVEX

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

BH

Owner Name

Type: Organization / Limited Liability Company

Address

100 Bayer Boulevard
Whippany, NJ 07981

Critical Dates

First Use Date

Apr 1, 2021

Filing Date

Oct 16, 2019

Registration Date

Jul 4, 2023

Mark Descriptions

Goods

Class 3
Non-medicated skin care preparations
Class 5
Preparation for the relief of pain; Topical analgesics

Mark Elements

Text Mark
ALEVEX
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Apr 1, 2021

Filing Date

Oct 16, 2019

Publication Date

Mar 3, 2020

Registration Date

Jul 4, 2023

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 06:14 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

ALEVEX is a standard character mark owned by Bayer HealthCare LLC covering non-medicated skin care preparations in International Class 003 and preparations for the relief of pain plus topical analgesics in International Class 005, with first use and first use in commerce for both dated April 1, 2021. The mark is registered on the Principal Register since July 4, 2023, under Registration Number 7101168. No active oppositions or legal proceedings are present.

Recent Activity

Filed on October 16, 2019, the application was published for opposition on March 3, 2020, followed by multiple statement of use extensions before the statement of use was accepted and the mark registered on July 4, 2023. Most recently, attorney and correspondence changes were recorded on December 17, 2024.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 06:14 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.